Cancer death rates declining, CDC says
March 30, 2016
Hepatitis C patients found to require lesser drugs for treatment
March 31, 2016
Show all

New Treatment for Multiple Sclerosis

A cancer treatment has been shown to have promising effects on multiple sclerosis patients.

A recent documentary by BBC Panorama showed a new, cutting-edge and potentially life-changing treatment for those suffering with multiple sclerosis.

Multiple sclerosis is a condition affecting nerves in the brain and spinal cord, which in turn affects balance, vision and movement of muscles, with many sufferers becoming unable to stand and requiring a wheelchair. Our central nervous system (CNS) contains the brain and the spinal cord, and each nerve within the CNS has a protective coating known as the myelin sheath. In multiple sclerosis this sheath is damaged, which affects nerve signalling and causes a variety of debilitating symptoms.

The condition is known as an ‘autoimmune’ condition as it involves our immune systems attacking ‘self’, in this case, it attacks nerves, which it should not normally do. The immune system usually remains silent until it is needed, for example during an infection. Unfortunately, MS sees the immune system incorrectly activated, damaging nerves in the brain and spinal cord which are usually protected by the myelin sheath.

A new treatment, currently being trialled in Sheffield’s Royal Hallamshire Hospital alongside hospitals in Sweden, the US and Brazil, has seen nothing short of astounding results in patients with relapsing remitting MS which accounts for around 80% of patients with this condition. It is commonly associated with mild periods and flare ups of the condition, during which symptoms can be life limiting.

Read Full Article: New Treatment for Multiple Sclerosis | Redbrick | University of Birmingham


The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.